Sysmex Corporation (SSMXF)
USD 16.24
(2.78%)
USD 16.24
(2.78%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 28.6 Billion JPY | 0.0% |
| 2023 | 15.44 Billion JPY | -2.51% |
| 2022 | 15.84 Billion JPY | -2.09% |
| 2021 | 16.17 Billion JPY | -4.47% |
| 2020 | 16.93 Billion JPY | 8766.49% |
| 2019 | 191 Million JPY | -46.35% |
| 2018 | 356 Million JPY | -33.33% |
| 2017 | 534 Million JPY | -27.15% |
| 2016 | 733 Million JPY | 268.34% |
| 2015 | 199 Million JPY | -44.1% |
| 2014 | 356 Million JPY | 44.72% |
| 2013 | 246 Million JPY | -5.75% |
| 2012 | 261 Million JPY | -53.56% |
| 2011 | 562 Million JPY | -30.45% |
| 2010 | 808 Million JPY | -62.51% |
| 2009 | 2.15 Billion JPY | 16476.92% |
| 2008 | 13 Million JPY | -84.15% |
| 2007 | 82 Million JPY | 2633.33% |
| 2006 | 3 Million JPY | -86.36% |
| 2005 | 22 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 28.6 Billion JPY | 85.21% |
| 2024 Q3 | 25 Billion JPY | 0.0% |
| 2024 Q2 | 17.54 Billion JPY | 0.0% |
| 2024 Q4 | 28.6 Billion JPY | 14.4% |
| 2024 Q1 | 17.39 Billion JPY | 0.0% |
| 2023 FY | 15.44 Billion JPY | -2.51% |
| 2023 Q1 | 16.83 Billion JPY | 6.29% |
| 2023 Q2 | 16.71 Billion JPY | -0.7% |
| 2023 Q3 | 15.32 Billion JPY | -8.33% |
| 2023 Q4 | 15.44 Billion JPY | 0.76% |
| 2022 Q2 | 15.31 Billion JPY | -3.75% |
| 2022 Q1 | 15.9 Billion JPY | -1.66% |
| 2022 Q3 | 15.21 Billion JPY | -0.67% |
| 2022 Q4 | 15.84 Billion JPY | 4.14% |
| 2022 FY | 15.84 Billion JPY | -2.09% |
| 2021 Q2 | 16.24 Billion JPY | -0.89% |
| 2021 Q4 | 16.17 Billion JPY | 4.84% |
| 2021 Q3 | 15.43 Billion JPY | -5.0% |
| 2021 Q1 | 16.39 Billion JPY | -3.22% |
| 2021 FY | 16.17 Billion JPY | -4.47% |
| 2020 Q3 | 17.08 Billion JPY | 1.53% |
| 2020 FY | 16.93 Billion JPY | 8766.49% |
| 2020 Q1 | 18.09 Billion JPY | 9375.92% |
| 2020 Q2 | 16.82 Billion JPY | -7.03% |
| 2020 Q4 | 16.93 Billion JPY | -0.87% |
| 2019 Q4 | 191 Million JPY | 0.0% |
| 2019 FY | 191 Million JPY | -46.35% |
| 2019 Q1 | - JPY | -100.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q1 | - JPY | -100.0% |
| 2018 FY | 356 Million JPY | -33.33% |
| 2018 Q4 | 356 Million JPY | 0.0% |
| 2018 Q2 | - JPY | 0.0% |
| 2017 Q4 | 534 Million JPY | 0.0% |
| 2017 Q2 | - JPY | 0.0% |
| 2017 Q1 | - JPY | -100.0% |
| 2017 FY | 534 Million JPY | -27.15% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 FY | 733 Million JPY | 268.34% |
| 2016 Q1 | - JPY | -100.0% |
| 2016 Q2 | - JPY | 0.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 Q4 | 733 Million JPY | 0.0% |
| 2015 Q4 | 199 Million JPY | 0.0% |
| 2015 Q2 | 91 Million JPY | -7.14% |
| 2015 FY | 199 Million JPY | -44.1% |
| 2015 Q1 | 98 Million JPY | -72.47% |
| 2015 Q3 | - JPY | -100.0% |
| 2014 Q4 | 356 Million JPY | 252.48% |
| 2014 FY | 356 Million JPY | 44.72% |
| 2014 Q3 | 101 Million JPY | -5.61% |
| 2014 Q2 | 107 Million JPY | 0.0% |
| 2014 Q1 | - JPY | -100.0% |
| 2013 Q4 | 246 Million JPY | 24500.0% |
| 2013 FY | 246 Million JPY | -5.75% |
| 2013 Q1 | 2 Million JPY | -99.23% |
| 2013 Q3 | 1 Million JPY | 0.0% |
| 2013 Q2 | 1 Million JPY | -50.0% |
| 2012 Q2 | 6 Million JPY | -33.33% |
| 2012 Q4 | 261 Million JPY | 5120.0% |
| 2012 FY | 261 Million JPY | -53.56% |
| 2012 Q1 | 9 Million JPY | -98.4% |
| 2012 Q3 | 5 Million JPY | -16.67% |
| 2011 Q4 | 562 Million JPY | 6144.44% |
| 2011 FY | 562 Million JPY | -30.45% |
| 2011 Q3 | 9 Million JPY | 350.0% |
| 2011 Q1 | 2 Million JPY | -99.75% |
| 2011 Q2 | 2 Million JPY | 0.0% |
| 2010 Q2 | 3 Million JPY | 0.0% |
| 2010 Q4 | 808 Million JPY | 26833.33% |
| 2010 FY | 808 Million JPY | -62.51% |
| 2010 Q3 | 3 Million JPY | 0.0% |
| 2009 Q3 | - JPY | 0.0% |
| 2009 Q4 | 2.15 Billion JPY | 0.0% |
| 2009 FY | 2.15 Billion JPY | 16476.92% |
| 2008 FY | 13 Million JPY | -84.15% |
| 2007 FY | 82 Million JPY | 2633.33% |
| 2006 FY | 3 Million JPY | -86.36% |
| 2005 FY | 22 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -3955.142% |
| Ansell Limited | 706.6 Million USD | -3947.552% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -127512.697% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -4575900.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -2234.374% |
| ConvaTec Group Plc | 1.22 Billion USD | -2231.078% |
| Encision Inc. | 67.33 Thousand USD | -42473465.403% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -7470442.293% |
| LifePoint, Inc. | 151.73 Thousand USD | -18848674.83% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -581910.582% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -4650306.504% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -15892055.61% |
| SmileDirectClub, Inc. | 849.37 Million USD | -3267.166% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -13468.656% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -58982349.628% |
| Vasamed, Inc. | 18.95 Thousand USD | -150923382.85% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -154862364.804% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -7324875.349% |